This press release is not intended for publication or distribution in the United States, Canada,…
MaaT PharmaFebruary 17, 2023
MaaT Pharma Receives U.S. FDA Response Outlining Path Forward for Investigational New Drug Application for…
MaaT PharmaFebruary 3, 2023
MaaT Pharma Announces Initiation of Coverage of its Stock by Kepler Cheuvreux Lyon, France, January…
MaaT PharmaJanuary 27, 2023
MaaT Pharma Provides Corporate Update and Highlights Key Expected Milestones in 2023 Lyon, France, January…
MaaT PharmaJanuary 24, 2023
MaaT Pharma: Half-year Report on Liquidity Contract With the Brokerage Firm Kepler Cheuvreux Lyon, France,…
MaaT PharmaJanuary 9, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaJanuary 6, 2023
